Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Destrin Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA124937
Description
Recommended positive controls: A431, PC-12, MDCK, NIH3T3. PA1-24937 detects a band of approximately 19 kDa. Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
The product of this gene belongs to the actin-binding proteins ADF family. This family of proteins is responsible for enhancing the turnover rate of actin in vivo. This gene encodes the actin depolymerizing protein that severs actin filaments (F-actin) and binds to actin monomers (G-actin). Two transcript variants encoding distinct isoforms have been identified for this gene.
Specifications
Destrin | |
Polyclonal | |
Unconjugated | |
DSTN | |
2610043P17Rik; ACTDP; actin depolymerizing factor; actin-depolymerizing factor; ADF; AU042046; bA462D18.2; bA462D18.2 (destrin (actin depolymerizing factor ADF) (ACTDP)); corn1; corneal disease 1; destrin; destrin (actin depolymerizing factor); destrin, actin depolymerizing factor; Dsn; DSTN; epididymis luminal protein 32; HEL32; RP23-77A2.1; sID; Sid 23; Sid23; sid23p | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
11034, 477147, 502674, 56431 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
1 mg/mL | |
PBS with 1% BSA and 15mM sodium azide | |
P60981, Q7M0E3, Q9R0P5 | |
DSTN | |
Synthetic peptide, conjugated to KLH, corresponding to residues 153-165 of Destrin with an N-terminal added lysine. | |
50 μL | |
Primary | |
Human, Mouse, Rat, Canine | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction